Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5780)
  3. Review (420)
  4. Editorial (195)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13275)
  2. Center for Hematologic Malignancies (10610)
  3. GSK Faculty (4481)
  4. Adult Leukemia (3673)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2704)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (337)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (330)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1530)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13376)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PD-1 blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: Results from a multicenter cohort
    Meeting Abstract

    Desai, S. H.; Merryman, R. W.; Shah, H.; Pederson, L. D.; Geyer, S. M.; Ganesan, N.; Chang, T.; Othman, T.; Falade, A. S.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of mutations in blood cancer-related genes on clinical outcomes in chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 tyrosine kinase inhibitors ( TKIs) in the Ascembl trial
    Meeting Abstract

    Branford, S.; Hochhaus, A.; Mauro, M.; Minami, Y.; Rea, D.; Freitas, Cmbd; Serrano-Fernandez, P.; Obourn, V.; Bruederle, A.; Espurz, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revised definition of free light chains in serum and light chain monoclonal gammopathy of undetermined significance: Results of the Istopmm study
    Meeting Abstract

    Long, T. E.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Sverrisdottir, I.; Eythorsson, E.; Indridason, O.; Palsson, R.; Aspelund, T.; Vidarsson, B.; Onundarson, P. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • UBA1 mutations identify a rare but distinct subtype of myelodysplastic syndromes
    Meeting Abstract

    Sirenko, M.; Bernard, E.; Creignou, M.; Domenico, D.; Farina, A.; Ossa, J. E. A.; Kosmider, O.; Hasserjian, R.; Jädersten, M.; Germing, U.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • RNA splicing factor mutations drive aberrant canonical and cryptic circular RNA biogenesis in leukemia
    Meeting Abstract

    Fernandez, M.; Jin, M.; Jia, Q.; Wu, Y.; Hart, K.; Bargoma, E.; Pangallo, J.; Bradley, R. K.; Abdel-Wahab, O.; Jia, Z.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Development of a fully immunocompetent adoptive transfer in vivo model of Npm1(cA); Idh2(R140Q); Flt3(ITD) AML
    Meeting Abstract

    Sharpe, C.; Johnson, M.; Fobare, S.; Elgamal, O. A.; Harrington, B. K.; Mustonen, A.; Bryant, K.; Cheney, C.; Lerma, J. R.; Truxall, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes from the MCL cohort of the phase 1, seamless design TRANSCEND NHL 001 study of lisocabtagene maraleucel in patients with R/R B-cell NHL
    Meeting Abstract

    Wang, M. L.; Gordon, L. I.; Hirayama, A. V.; Lunning, M. A.; Shi, L.; Guo, S.; Kostic, A.; Eliason, L.; Kumar, J.; Palomba, M. L.
    Blood (2023)

    Fulltext@MSK | Save
  • What is the optimal treatment modality in molecularly defined secondary AML? A multicenter cohort study
    Meeting Abstract

    Shimony, S.; Bewersdorf, J. P.; Shallis, R. M.; Liu, Y. W.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Chen, E. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell LyLisocabtagene maraleucel in relapsed/refractory large B-cell lymphoma: Real world analysis from the Cell Therapy Consortiummphoma: Real World Analysis from the Cell Therapy Consortium
    Meeting Abstract

    Riedell, P. A.; Grady, C.; Nastoupil, L. J.; Luna, A.; Ahmed, N.; Maziarz, R. T.; Hu, M.; Brower, J.; Hwang, W. T.; Schuster, S. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes of brexucabtagene autoleucel ( brexu-cel) for relapsed or refractory (R/R) adult B-cell acute lymphoblastic leukemia (B-cell ALL): Evidence from the CIBMTR registry
    Meeting Abstract

    Bezerra, E.; Itani, T.; Wudhikarn, K.; Perales, M. A.; Yang, Y.; Gergis, U.; Aribi, A.; Hill, L. C.; Jain, N.; Leonard, J. T.; more...
    Blood (2023)

    Fulltext@MSK | Save